annb0t
Top 20
MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology platform, and a protein engineering and discovery research facility to enhance existing innovation capabilities.(PRNewsfoto/Te...
>>> Read more: Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
>>> Read more: Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
